ADC THERAPEUTICS SA (ADCT:NYSE)
$1.29 -0.01 (-0.7692%)
Analysed ADC THERAPEUTICS SA (ADCT:NYSE) News Sources
An ADC specialist sinks on safety concerns for blood cancer drug
04-06-2026
biopharmadive.com
ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data
04-06-2026
yahoo.com
Top Midday Decliners
04-06-2026
yahoo.com
ADC Therapeutics (ADCT) Is Down 69.7% After Mixed LOTIS-5 ZYNLONTA Data - Has The Bull Case Changed?
08-06-2026
yahoo.com
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
24-06-2026
yahoo.com
ADC Therapeutics To Cut About 17% Of Its Staff – A Look At Some Key Details
24-06-2026
stocktwits.com
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Analyst Views
27-06-2026
yahoo.com
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
30-06-2026
yahoo.com
ADC Therapeutics Announces New Employee Inducement Grant
01-07-2026
yahoo.com
The Cancer Therapy Strategy VERAXA Is Betting the Company On
06-07-2026
yahoo.com
What is the current price of ADC THERAPEUTICS SA (ADCT:NYSE)?
The current price of ADC THERAPEUTICS SA (ADCT:NYSE) is $1.29.
ADC THERAPEUTICS SA (ADCT:NYSE) absolute price change since previous trading day?
The absolute price change of ADC THERAPEUTICS SA (ADCT:NYSE) since the previous trading day is $-0.01.
ADC THERAPEUTICS SA (ADCT:NYSE) percentage price change since previous trading day?
The percentage price change of ADC THERAPEUTICS SA (ADCT:NYSE) since the previous trading day is -0.7692%.
What is the most recent average sentiment score for ADC THERAPEUTICS SA (ADCT:NYSE)?
The most recent average sentiment score for ADC THERAPEUTICS SA (ADCT:NYSE) is 58 out of 100.
What is the most recent average sentiment for ADC THERAPEUTICS SA (ADCT:NYSE)?
The most recent sentiment for ADC THERAPEUTICS SA (ADCT:NYSE) is .
SEC-8K** Filing Available For ADC THERAPEUTICS SA (ADCT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.